s/
Stockslash
⌘K
Stocks
EVH
Not investment advice · 13F data lagged ~45 days · Full disclaimer
EV

Evolent Health

EVH13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 1 fund we track owns this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying EVH

Top funds mostly trimmed Evolent Health in Q2 (Apr⁠–⁠Jun)

Buying:
FundsInsidersCongress
1 fund$30.2M held9.3% avg. weightQ2: 0 bought / 1 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026
Insider trades (Form 4)
Last 2 years · 12 filings
Net buying$1.71M
DateInsiderTypeSharesPriceValue
Aug 26, 2026
Daniel Joseph Mccarthy
President
Sold65,892$5.00$329K
Nov 18, 2025
Brendan B Springstubb
Director
Bought10,000$3.82$38K
Mar 6, 2025
Diane Holder
Director
Bought2,735$9.33$26K
Mar 6, 2025
Daniel Joseph Mccarthy
President
Bought11,040$9.01$99K
Mar 7, 2025
Richard M Jelinek
Director
Bought30,000$9.13$274K
Mar 6, 2025
Peter J Grua
Director
Bought11,040$9.01$99K
Mar 6, 2025
Seth Blackley
CEO
Bought55,225$9.01$498K
Mar 7, 2025
Brendan B Springstubb
Director
Bought15,000$9.27$139K
Mar 6, 2025
Russell Monroe Glass
Director
Bought5,400$9.27$50K
Mar 7, 2025
Kim Keck
Director
Bought10,540$9.44$99K
Mar 6, 2025
Craig A. Barbarosh
Director
Bought2,000$8.81$18K
Mar 4, 2025
Brendan B Springstubb
Director
Bought5,000$8.75$44K